S100P and colorectal carcinoma: Another important target of SOX9 is S100P; both were coexpressed in CRC and the knockdown of SOX9 expression downregulates S100P expression resulting in reduced invasiveness and metastasis of colon cancer cells by inhibiting the activation of receptor for advanced glycation end products (RAGE)/ERK signaling and EMT [55].